Zhenting Gao

Title: Zhenting Gao: Innovator in Anti-Cancer Research

Introduction

Zhenting Gao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the development of anti-cancer agents. His work focuses on innovative solutions to combat diseases mediated by mixed lineage leukemia 1 (MLL1).

Latest Patents

Zhenting Gao holds a patent for MLL1 inhibitors and anti-cancer agents. The present invention provides a compound of Formula (I) or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof. The variables in the formula are defined within the patent documentation. Furthermore, the invention includes pharmaceutical compositions comprising such compounds and methods for using these compounds to treat diseases associated with MLL1. He has 1 patent to his name.

Career Highlights

Throughout his career, Zhenting Gao has worked with notable organizations, including China Novartis Institutes for Biomedical Research Co., Ltd. and Novartis AG. His experience in these companies has allowed him to contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Zhenting Gao has collaborated with esteemed colleagues such as Haibing Guo and Jun Zhu. Their combined expertise has further advanced the research and development of innovative treatments in the field of oncology.

Conclusion

Zhenting Gao's work in developing MLL1 inhibitors showcases his dedication to advancing cancer treatment. His contributions to biomedical research continue to impact the field positively.